AJMC November 6, 2022
Daniel E. Weiner, MD, MS, board certified nephrologist and lead navigator at Tufts Clinical and Translational Science Institute, spoke on the limitations and future potential of value-based payment systems for chronic kidney disease (CKD), including the End-Stage Renal Disease (ESRD) Treatment Choices (ETC) Model and the Kidney Care Choices (KCC) Models.
There are several shortcomings with current value-based payment models available for the management of chronic kidney disease (CKD), but some incentives, such as the Kidney Transplant Bonus, show the potential benefits of a pay it forward approach that can be impactful for other sectors of health care, said Daniel E. Weiner, MD, MS, board certified nephrologist and lead navigator at Tufts Clinical and Translational Science Institute.
Weiner spoke during...
Today's Sponsors
Today's Sponsor